Global Precision Medicine Market Trend and Development Strategy Analysis 2023-2029
Market Analysis and Insights: Global Precision Medicine Market
The global Precision Medicine market size in 2022 is 7330.0 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 12.60% expected in 2023-2029.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Precision Medicine market include Moderna, Inc. (U.S.), Personalis, Inc. (U.S.), CureVac SE (Germany), Celldex Therapeutics (U.S.), and BioNTech SE (Germany). The share of the top 3 players in the Precision Medicine market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Precision Medicine market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Alectinib accounted for XX% of Precision Medicine market in 2022. Osimertinib share of XX%.
Oncology accounted for XX% of the Precision Medicine market in 2022. Central Nervous System (CNS) Disorders accounts for XX%.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Precision Medicine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Precision Medicine market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Precision Medicine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Precision Medicine market.
Global Precision Medicine Scope and Market Size
Precision Medicine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Precision Medicine market will be able to gain the upper hand as they use the report as a powerful resource.
The impact of the outbreak of COVID-19 and the Russia-Ukraine War on the Precision Medicine industry is considered in the report, covering the dynamic analysis of the development of the Precision Medicine industry, including trends, technologies, opportunities, constraints. To ensure report buyers are able to gain in-depth knowledge of the market.
The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.
Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.
Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.
Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.
Market Data Breakdown by Regions
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Spain
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Egypt
South Africa
UAE
Turkey
Saudi Arabia
Some prominent players in the market includes:
Moderna, Inc. (U.S.)
Personalis, Inc. (U.S.)
CureVac SE (Germany)
Celldex Therapeutics (U.S.)
BioNTech SE (Germany)
Advaxis, Inc. (U.S.)
Agenus Inc. (U.S.)
Immatics Biotechnologies GmbH (Germany)
Gritstone Oncology (U.S.)
ImmunityBio, Inc. (U.S.)
bioMérieux SA (France)
Bayer AG (Germany)
Pfizer Inc. (U.S.)
GSK plc (U.K.)
F. Hoffmann-La Roche Ltd. (Switzerland)
Market Data Breakdown by Type
Alectinib
Osimertinib
Mepolizumab
Aripiprazole Lauroxil,
Others
Market Data Breakdown by Applications
Oncology
Central Nervous System (CNS) Disorders
Immunology Disorders
Respiratory Disorders
Others
Table of Content
1 Precision Medicine Market Introduction and Overview
1.1 Precision Medicine Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Precision Medicine Industry Dynamic Analysis
1.5.1 Precision Medicine Market Trends Analysis
1.5.2 Precision Medicine Market Drivers Analysis
1.5.3 Precision Medicine Market Challenges Analysis
1.5.4 Precision Medicine Market Restraints Analysis
1.6 Inflation Analysis
1.7 The Impact of the Russian-Ukrainian War on the Market
1.8 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Precision Medicine Market Insights by Type
2.1 Market Size Insights by Types
2.2 Global Precision Medicine Revenue and Share by Type
3 Global Precision Medicine Market Insights by Application
3.1 Market Size Insights by Application
3.2 Global Precision Medicine Revenue and Share by Application (2018-2023)
4 Global Market Growth Insights
4.1 Global Precision Medicine Market Size (2018-2023)
4.2 Precision Medicine Growth Insights by Regions
4.2.1 Precision Medicine Market Size by Regions: 2018 VS 2023 VS 2029
4.2.2 Precision Medicine Revenue Market Size by Regions (2018-2023)
4.2.3 North America Precision Medicine Market Size (2018-2023)
4.2.4 Europe Precision Medicine Market Size (2018-2023)
4.2.5 Asia-Pacific Precision Medicine Market Size (2018-2023)
4.2.6 Latin America Precision Medicine Market Size (2018-2023)
4.2.7 Middle East & Africa Precision Medicine Market Size (2018-2023)
5 North America
5.1 North America Precision Medicine Revenue by Countries
5.1.1 North America Precision Medicine Revenue by Countries (2018-2023)
5.2 North America PEST Analysis
5.3 United States
5.4 Canada
6 Asia Pacific
6.1 Asia Pacific Precision Medicine Revenue by Countries
6.1.1 Asia Pacific Precision Medicine Revenue by Countries (2018-2023)
6.2 Asia-Pacific PEST Analysis
6.3 China
6.4 Japan
6.5 Korea
6.6 Southeast Asia
6.7 India
6.8 Australia
7 Europe
7.1 Europe Precision Medicine Revenue by Countries
7.1.1 Europe Precision Medicine Revenue by Countries (2018-2023)
7.2 Europe PEST Analysis
7.3 Germany
7.4 France
7.5 UK
7.6 Italy
7.7 Russia
7.8 Spain
7.9 Nordic
8 Latin America
8.1 Latin America Precision Medicine Revenue by Countries
8.1.1 Latin America Precision Medicine Revenue by Countries (2018-2023)
8.2 Latin America PEST Analysis
8.3 Brazil
8.4 Argentina
8.5 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Precision Medicine Revenue by Countries
9.1.1 Middle East & Africa Precision Medicine Revenue by Countries (2018-2023)
9.2 Middle East & Africa PEST Analysis
9.3 Egypt
9.4 South Africa
9.5 UAE
9.6 Turkey
9.7 Saudi Arabia
10 Global Precision Medicine Market Competition, by Players
10.1 Global Precision Medicine Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Precision Medicine Players Market Share in 2022
10.2.2 Top 6 Precision Medicine Players Market Share in 2022
10.2.3 Market Competition Trend
10.3 Precision Medicine Players Head Office, Business Provided
10.4 Precision Medicine Mergers & Acquisitions
10.5 Precision Medicine New Entrants and Expansion Plans
11 Players Profiles
11.1 Moderna, Inc. (U.S.)
11.1.1 Moderna, Inc. (U.S.) Company Profile
11.1.2 Precision Medicine Product Overview
11.1.3 Moderna, Inc. (U.S.) Precision Medicine Market Performance (2018-2023)
11.1.4 Moderna, Inc. (U.S.) Business Overview
11.1.5 Recent Developments and Plans
11.2 Personalis, Inc. (U.S.)
11.2.1 Personalis, Inc. (U.S.) Company Profile
11.2.2 Precision Medicine Product Overview
11.2.3 Personalis, Inc. (U.S.) Precision Medicine Market Performance (2018-2023)
11.2.4 Personalis, Inc. (U.S.) Business Overview
11.2.5 Recent Developments and Plans
11.3 CureVac SE (Germany)
11.3.1 CureVac SE (Germany) Company Profile
11.3.2 Precision Medicine Product Overview
11.3.3 CureVac SE (Germany) Precision Medicine Market Performance (2018-2023)
11.3.4 CureVac SE (Germany) Business Overview
11.3.5 Recent Developments and Plans
11.4 Celldex Therapeutics (U.S.)
11.4.1 Celldex Therapeutics (U.S.) Company Profile
11.4.2 Precision Medicine Product Overview
11.4.3 Celldex Therapeutics (U.S.) Precision Medicine Market Performance (2018-2023)
11.4.4 Celldex Therapeutics (U.S.) Business Overview
11.4.5 Recent Developments and Plans
11.5 BioNTech SE (Germany)
11.5.1 BioNTech SE (Germany) Company Profile
11.5.2 Precision Medicine Product Overview
11.5.3 BioNTech SE (Germany) Precision Medicine Market Performance (2018-2023)
11.5.4 BioNTech SE (Germany) Business Overview
11.5.5 Recent Developments and Plans
11.6 Advaxis, Inc. (U.S.)
11.6.1 Advaxis, Inc. (U.S.) Company Profile
11.6.2 Precision Medicine Product Overview
11.6.3 Advaxis, Inc. (U.S.) Precision Medicine Market Performance (2018-2023)
11.6.4 Advaxis, Inc. (U.S.) Business Overview
11.6.5 Recent Developments and Plans
11.7 Agenus Inc. (U.S.)
11.7.1 Agenus Inc. (U.S.) Company Profile
11.7.2 Precision Medicine Product Overview
11.7.3 Agenus Inc. (U.S.) Precision Medicine Market Performance (2018-2023)
11.7.4 Agenus Inc. (U.S.) Business Overview
11.7.5 Recent Developments and Plans
11.8 Immatics Biotechnologies GmbH (Germany)
11.8.1 Immatics Biotechnologies GmbH (Germany) Company Profile
11.8.2 Precision Medicine Product Overview
11.8.3 Immatics Biotechnologies GmbH (Germany) Precision Medicine Market Performance (2018-2023)
11.8.4 Immatics Biotechnologies GmbH (Germany) Business Overview
11.8.5 Recent Developments and Plans
11.9 Gritstone Oncology (U.S.)
11.9.1 Gritstone Oncology (U.S.) Company Profile
11.9.2 Precision Medicine Product Overview
11.9.3 Gritstone Oncology (U.S.) Precision Medicine Market Performance (2018-2023)
11.9.4 Gritstone Oncology (U.S.) Business Overview
11.9.5 Recent Developments and Plans
11.10 ImmunityBio, Inc. (U.S.)
11.10.1 ImmunityBio, Inc. (U.S.) Company Profile
11.10.2 Precision Medicine Product Overview
11.10.3 ImmunityBio, Inc. (U.S.) Precision Medicine Market Performance (2018-2023)
11.10.4 ImmunityBio, Inc. (U.S.) Business Overview
11.10.5 Recent Developments and Plans
11.11 bioMérieux SA (France)
11.11.1 bioMérieux SA (France) Company Profile
11.11.2 Precision Medicine Product Overview
11.11.3 bioMérieux SA (France) Precision Medicine Market Performance (2018-2023)
11.11.4 bioMérieux SA (France) Business Overview
11.11.5 Recent Developments and Plans
11.12 Bayer AG (Germany)
11.12.1 Bayer AG (Germany) Company Profile
11.12.2 Precision Medicine Product Overview
11.12.3 Bayer AG (Germany) Precision Medicine Market Performance (2018-2023)
11.12.4 Bayer AG (Germany) Business Overview
11.12.5 Recent Developments and Plans
11.13 Pfizer Inc. (U.S.)
11.13.1 Pfizer Inc. (U.S.) Company Profile
11.13.2 Precision Medicine Product Overview
11.13.3 Pfizer Inc. (U.S.) Precision Medicine Market Performance (2018-2023)
11.13.4 Pfizer Inc. (U.S.) Business Overview
11.13.5 Recent Developments and Plans
11.14 GSK plc (U.K.)
11.14.1 GSK plc (U.K.) Company Profile
11.14.2 Precision Medicine Product Overview
11.14.3 GSK plc (U.K.) Precision Medicine Market Performance (2018-2023)
11.14.4 GSK plc (U.K.) Business Overview
11.14.5 Recent Developments and Plans
11.15 F. Hoffmann-La Roche Ltd. (Switzerland)
11.15.1 F. Hoffmann-La Roche Ltd. (Switzerland) Company Profile
11.15.2 Precision Medicine Product Overview
11.15.3 F. Hoffmann-La Roche Ltd. (Switzerland) Precision Medicine Market Performance (2018-2023)
11.15.4 F. Hoffmann-La Roche Ltd. (Switzerland) Business Overview
11.15.5 Recent Developments and Plans
12 Global Precision Medicine Forecast Market Insights by Type
12.1 Global Precision Medicine Revenue Market Forecast by Type (2023-2029)
13 Global Precision Medicine Forecast Market Insights by Application
13.1 Precision Medicine Revenue Market Forecast by Application (2023-2029)
14 Global Market Growth Forecast Insights
14.1 Global Precision Medicine Forecast Market Size (2023-2029)
14.2 Precision Medicine Growth Forecast Insights by Regions
14.2.1 Precision Medicine Revenue Forecast Market Size by Regions (2023-2029)
14.2.2 North America Precision Medicine Forecast Market Size (2023-2029)
14.2.3 Europe Precision Medicine Forecast Market Size (2023-2029)
14.2.4 Asia-Pacific Precision Medicine Forecast Market Size (2023-2029)
14.2.5 Latin America Precision Medicine Forecast Market Size (2023-2029)
14.2.6 Middle East & Africa Precision Medicine Forecast Market Size (2023-2029)
15 Methodology and Data Source
15.1 A Methodology
15.1.1 Research Process
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 B Data Source
15.2.1 Legal Disclaimer
List of Tables and Figures
Figure Precision Medicine Picture
Table Product Definition of Precision Medicine
Table Economic Analysis of Global Regions
Table Market Trends Analysis
Table Market Drivers Analysis
Table Market Challenges Analysis
Table Market Restraints Analysis
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Figure 2020 (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Global Precision Medicine Market Size by Type (2018 VS 2023 VS 2029)
Table Global Precision Medicine Revenue by Type (2018-2023)
Table Global Precision Medicine Revenue and Share by Type (2018-2023)
Table Global Precision Medicine Market Size by Application (2018 VS 2023 VS 2029)
Table Global Precision Medicine Revenue by Application (2018-2023)
Table Global Precision Medicine Revenue Share by Application (2018-2023)
Figure Global Precision Medicine Revenue Market Size Growth (2018-2023)
Table Precision Medicine Market Size by Regions: 2018 VS 2023 VS 2029
Table Precision Medicine Revenue Market Size by Regions (2018-2023)
Table Precision Medicine Revenue and Share by Regions (2018-2023)
Figure North America Precision Medicine Market Size (2018-2023)
Figure Europe Precision Medicine Market Size (2018-2023)
Figure Asia-Pacific Precision Medicine Market Size (2018-2023)
Figure Latin America Precision Medicine Market Size (2018-2023)
Figure Middle East & Africa Precision Medicine Market Size (2018-2023)
Table North America Precision Medicine Revenue by Countries (2018-2023)
Table North America Precision Medicine Revenue and Share by Countries (2018-2023)
Table North America PEST Analysis
Figure United States Precision Medicine Revenue and Growth (2018-2023)
Figure Canada Precision Medicine Revenue and Growth (2018-2023)
Figure Canada Precision Medicine Sales and Growth (2018-2023)
Table Asia-Pacific Precision Medicine Revenue by Countries (2018-2023)
Table Asia-Pacific Precision Medicine Revenue and Share by Countries (2018-2023)
Table Asia-Pacific PEST Analysis
Figure China Precision Medicine Revenue and Growth (2018-2023)
Figure Japan Precision Medicine Revenue and Growth (2018-2023)
Figure Korea Precision Medicine Revenue and Growth (2018-2023)
Figure Southeast Asia Precision Medicine Revenue and Growth (2018-2023)
Figure India Precision Medicine Revenue and Growth (2018-2023)
Figure Australia Precision Medicine Revenue and Growth (2018-2023)
Table Europe Precision Medicine Revenue by Countries (2018-2023)
Table Europe Precision Medicine Revenue and Share by Countries (2018-2023)
Table Europe PEST Analysis
Figure Germany Precision Medicine Revenue and Growth (2018-2023)
Figure France Precision Medicine Revenue and Growth (2018-2023)
Figure UK Precision Medicine Revenue and Growth (2018-2023)
Figure Italy Precision Medicine Revenue and Growth (2018-2023)
Figure Russia Precision Medicine Revenue and Growth (2018-2023)
Figure Spain Precision Medicine Revenue and Growth (2018-2023)
Figure Nordic Precision Medicine Revenue and Growth (2018-2023)
Table Latin America Precision Medicine Revenue by Countries (2018-2023)
Table Latin America Precision Medicine Revenue and Share by Countries (2018-2023)
Table Latin America PEST Analysis
Figure Brazil Precision Medicine Revenue and Growth (2018-2023)
Figure Argentina Precision Medicine Revenue and Growth (2018-2023)
Figure Mexico Precision Medicine Revenue and Growth (2018-2023)
Table Middle East & Africa Precision Medicine Revenue by Countries (2018-2023)
Table Middle East & Africa Precision Medicine Revenue and Share by Countries (2018-2023)
Table Middle East & Africa PEST Analysis
Figure Egypt Precision Medicine Revenue and Growth (2018-2023)
Figure South Africa Precision Medicine Revenue and Growth (2018-2023)
Figure UAE Precision Medicine Revenue and Growth (2018-2023)
Figure Turkey Precision Medicine Revenue and Growth (2018-2023)
Figure Saudi Arabia Precision Medicine Revenue and Growth (2018-2023)
Table Global Precision Medicine Revenue by Players (2018-2023)
Table Global Precision Medicine Revenue Market Share by Players (2018-2023)
Figure Global Top 3 Companies Revenue Share in 2022
Figure Global Top 6 Companies Revenue Share in 2022
Table Global Precision Medicine Players Market Concentration Ratio (CR5) (2018-2023)
Table Precision Medicine Players Head Office, Business Provided
Table Mergers & Acquisitions
Table New Entrants and Expansion Plans
Table Moderna, Inc. (U.S.) Profile
Table Product Overview
Table Moderna, Inc. (U.S.) Precision Medicine Revenue, Gross and Gross Margin (2018-2023)
Figure Moderna, Inc. (U.S.) Revenue and Growth Rate
Figure Moderna, Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Personalis, Inc. (U.S.) Profile
Table Product Overview
Table Personalis, Inc. (U.S.) Precision Medicine Revenue, Gross and Gross Margin (2018-2023)
Figure Personalis, Inc. (U.S.) Revenue and Growth Rate
Figure Personalis, Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table CureVac SE (Germany) Profile
Table Product Overview
Table CureVac SE (Germany) Precision Medicine Revenue, Gross and Gross Margin (2018-2023)
Figure CureVac SE (Germany) Revenue and Growth Rate
Figure CureVac SE (Germany) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Celldex Therapeutics (U.S.) Profile
Table Product Overview
Table Celldex Therapeutics (U.S.) Precision Medicine Revenue, Gross and Gross Margin (2018-2023)
Figure Celldex Therapeutics (U.S.) Revenue and Growth Rate
Figure Celldex Therapeutics (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table BioNTech SE (Germany) Profile
Table Product Overview
Table BioNTech SE (Germany) Precision Medicine Revenue, Gross and Gross Margin (2018-2023)
Figure BioNTech SE (Germany) Revenue and Growth Rate
Figure BioNTech SE (Germany) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Advaxis, Inc. (U.S.) Profile
Table Product Overview
Table Advaxis, Inc. (U.S.) Precision Medicine Revenue, Gross and Gross Margin (2018-2023)
Figure Advaxis, Inc. (U.S.) Revenue and Growth Rate
Figure Advaxis, Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Agenus Inc. (U.S.) Profile
Table Product Overview
Table Agenus Inc. (U.S.) Precision Medicine Revenue, Gross and Gross Margin (2018-2023)
Figure Agenus Inc. (U.S.) Revenue and Growth Rate
Figure Agenus Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Immatics Biotechnologies GmbH (Germany) Profile
Table Product Overview
Table Immatics Biotechnologies GmbH (Germany) Precision Medicine Revenue, Gross and Gross Margin (2018-2023)
Figure Immatics Biotechnologies GmbH (Germany) Revenue and Growth Rate
Figure Immatics Biotechnologies GmbH (Germany) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Gritstone Oncology (U.S.) Profile
Table Product Overview
Table Gritstone Oncology (U.S.) Precision Medicine Revenue, Gross and Gross Margin (2018-2023)
Figure Gritstone Oncology (U.S.) Revenue and Growth Rate
Figure Gritstone Oncology (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table ImmunityBio, Inc. (U.S.) Profile
Table Product Overview
Table ImmunityBio, Inc. (U.S.) Precision Medicine Revenue, Gross and Gross Margin (2018-2023)
Figure ImmunityBio, Inc. (U.S.) Revenue and Growth Rate
Figure ImmunityBio, Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table bioMérieux SA (France) Profile
Table Product Overview
Table bioMérieux SA (France) Precision Medicine Revenue, Gross and Gross Margin (2018-2023)
Figure bioMérieux SA (France) Revenue and Growth Rate
Figure bioMérieux SA (France) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Bayer AG (Germany) Profile
Table Product Overview
Table Bayer AG (Germany) Precision Medicine Revenue, Gross and Gross Margin (2018-2023)
Figure Bayer AG (Germany) Revenue and Growth Rate
Figure Bayer AG (Germany) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Pfizer Inc. (U.S.) Profile
Table Product Overview
Table Pfizer Inc. (U.S.) Precision Medicine Revenue, Gross and Gross Margin (2018-2023)
Figure Pfizer Inc. (U.S.) Revenue and Growth Rate
Figure Pfizer Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table GSK plc (U.K.) Profile
Table Product Overview
Table GSK plc (U.K.) Precision Medicine Revenue, Gross and Gross Margin (2018-2023)
Figure GSK plc (U.K.) Revenue and Growth Rate
Figure GSK plc (U.K.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table F. Hoffmann-La Roche Ltd. (Switzerland) Profile
Table Product Overview
Table F. Hoffmann-La Roche Ltd. (Switzerland) Precision Medicine Revenue, Gross and Gross Margin (2018-2023)
Figure F. Hoffmann-La Roche Ltd. (Switzerland) Revenue and Growth Rate
Figure F. Hoffmann-La Roche Ltd. (Switzerland) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Global Precision Medicine Revenue Forecast by Type (2023-2029)
Table Global Precision Medicine Revenue and Share Forecast by Type (2023-2029)
Table Global Precision Medicine Revenue by Application (2023-2029)
Table Global Precision Medicine Revenue and Share by Application (2023-2029)
Figure Global Precision Medicine Revenue Forecast Market Size (2023-2029)
Table Precision Medicine Revenue Forecast by Regions (2023-2029)
Table Precision Medicine Revenue and Share Forecast by Regions (2023-2029)
Figure North America Precision Medicine Revenue Forecast Market Size (2023-2029)
Figure Europe Precision Medicine Revenue Forecast Market Size (2023-2029)
Figure Asia-Pacific Precision Medicine Revenue Forecast Market Size (2023-2029)
Figure Latin America Precision Medicine Revenue Forecast Market Size (2023-2029)
Figure Middle East & Africa Precision Medicine Revenue Forecast Market Size (2023-2029)
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|